Catamount Wealth Management’s Precigen PGEN Stock Holding History

Catamount Wealth Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,500	Closed	-$27K	–	207
2018 Q4	$27K	Sell	3,500 -500	-13%	-$5.6K	0.02%	88
2018 Q3	$69K	Sell	4,000 -2,000	-33%	-$29.7K	0.03%	70
2018 Q2	$90K	Buy	+6,000	New	+$101K	0.04%	60
2017 Q4	–	Sell	-6,500	Closed	-$96.8K	–	204
2017 Q3	$124K	Sell	6,500 -1,000	-13%	-$20.6K	0.07%	44
2017 Q2	$181K	Hold	7,500	–	–	0.11%	40
2017 Q1	$149K	Sell	7,500 -68	-0.9%	-$1.52K	0.1%	43
2016 Q4	$182K	Hold	7,568	–	–	0.15%	39
2016 Q3	$216K	Buy	7,568 +5,045	+200%	+$133K	0.19%	34
2016 Q2	$62K	Sell	2,523 -3,228	-56%	-$91.6K	0.07%	41
2016 Q1	$193K	Sell	5,751 -1,463	-20%	-$46.1K	0.22%	25
2015 Q4	$216K	Buy	7,214 +6,205	+615%	+$209K	0.2%	25
2015 Q3	$32K	Buy	+1,009	New	+$49.2K	0.03%	60

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Catamount Wealth Management's PGEN Position: Q1 2019 in Review

Catamount Wealth Management sold out of Precigen (PGEN) in Q1 2019, closing a stake of 3,500 shares — an estimated $27K sold.

Catamount Wealth Management first reported a position in PGEN in Q3 2015 and held it in 12 quarters. The position peaked at $216K in Q3 2016. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

Catamount Wealth Management reported no remaining Precigen position as of Q1 2019 after selling out during the quarter.
Catamount Wealth Management sold 3,500 Precigen shares in Q1 2019, an estimated $27K.
Catamount Wealth Management first reported a position in Precigen in Q3 2015 and held it in 12 quarters.
Catamount Wealth Management's Precigen position peaked at $216K in Q3 2016.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.